These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
129 related articles for article (PubMed ID: 24788101)
1. Molecular pathways: harnessing E2F1 regulation for prosenescence therapy in p53-defective cancer cells. Laine A; Westermarck J Clin Cancer Res; 2014 Jul; 20(14):3644-50. PubMed ID: 24788101 [TBL] [Abstract][Full Text] [Related]
2. Senescence sensitivity of breast cancer cells is defined by positive feedback loop between CIP2A and E2F1. Laine A; Sihto H; Come C; Rosenfeldt MT; Zwolinska A; Niemelä M; Khanna A; Chan EK; Kähäri VM; Kellokumpu-Lehtinen PL; Sansom OJ; Evan GI; Junttila MR; Ryan KM; Marine JC; Joensuu H; Westermarck J Cancer Discov; 2013 Feb; 3(2):182-97. PubMed ID: 23306062 [TBL] [Abstract][Full Text] [Related]
3. E2F-1 is a critical modulator of cellular senescence in human cancer. Park C; Lee I; Kang WK Int J Mol Med; 2006 May; 17(5):715-20. PubMed ID: 16596252 [TBL] [Abstract][Full Text] [Related]
4. E2F1-dependent pathways are involved in amonafide analogue 7-d-induced DNA damage, G2/M arrest, and apoptosis in p53-deficient K562 cells. Li Y; Shao J; Shen K; Xu Y; Liu J; Qian X J Cell Biochem; 2012 Oct; 113(10):3165-77. PubMed ID: 22593008 [TBL] [Abstract][Full Text] [Related]
5. Translating DNA damage into cancer cell death-A roadmap for E2F1 apoptotic signalling and opportunities for new drug combinations to overcome chemoresistance. Engelmann D; Pützer BM Drug Resist Updat; 2010; 13(4-5):119-31. PubMed ID: 20675184 [TBL] [Abstract][Full Text] [Related]
6. The E2F1/Rb and p53/MDM2 pathways in DNA repair and apoptosis: understanding the crosstalk to develop novel strategies for prostate cancer radiotherapy. Udayakumar T; Shareef MM; Diaz DA; Ahmed MM; Pollack A Semin Radiat Oncol; 2010 Oct; 20(4):258-66. PubMed ID: 20832018 [TBL] [Abstract][Full Text] [Related]
7. Regulation of replicative and stress-induced senescence by RSK4, which is down-regulated in human tumors. López-Vicente L; Armengol G; Pons B; Coch L; Argelaguet E; Lleonart M; Hernández-Losa J; de Torres I; Ramon y Cajal S Clin Cancer Res; 2009 Jul; 15(14):4546-53. PubMed ID: 19584160 [TBL] [Abstract][Full Text] [Related]
10. Role of p53 and p21waf1/cip1 in senescence-like terminal proliferation arrest induced in human tumor cells by chemotherapeutic drugs. Chang BD; Xuan Y; Broude EV; Zhu H; Schott B; Fang J; Roninson IB Oncogene; 1999 Aug; 18(34):4808-18. PubMed ID: 10490814 [TBL] [Abstract][Full Text] [Related]
11. The E2F family and the role of E2F1 in apoptosis. Wu Z; Zheng S; Yu Q Int J Biochem Cell Biol; 2009 Dec; 41(12):2389-97. PubMed ID: 19539777 [TBL] [Abstract][Full Text] [Related]
12. E2F1 suppresses skin carcinogenesis via the ARF-p53 pathway. Russell JL; Weaks RL; Berton TR; Johnson DG Oncogene; 2006 Feb; 25(6):867-76. PubMed ID: 16205640 [TBL] [Abstract][Full Text] [Related]
13. E2F1 mediates ectopic proliferation and stage-specific p53-dependent apoptosis but not aberrant differentiation in the ocular lens of Rb deficient fetuses. Liu Y; Zacksenhaus E Oncogene; 2000 Dec; 19(52):6065-73. PubMed ID: 11146559 [TBL] [Abstract][Full Text] [Related]
14. Escape from premature senescence is not sufficient for oncogenic transformation by Ras. Peeper DS; Dannenberg JH; Douma S; te Riele H; Bernards R Nat Cell Biol; 2001 Feb; 3(2):198-203. PubMed ID: 11175753 [TBL] [Abstract][Full Text] [Related]
15. E2F1 uses the ATM signaling pathway to induce p53 and Chk2 phosphorylation and apoptosis. Powers JT; Hong S; Mayhew CN; Rogers PM; Knudsen ES; Johnson DG Mol Cancer Res; 2004 Apr; 2(4):203-14. PubMed ID: 15140942 [TBL] [Abstract][Full Text] [Related]
16. p53 in breast cancer subtypes and new insights into response to chemotherapy. Bertheau P; Lehmann-Che J; Varna M; Dumay A; Poirot B; Porcher R; Turpin E; Plassa LF; de Roquancourt A; Bourstyn E; de Cremoux P; Janin A; Giacchetti S; Espié M; de Thé H Breast; 2013 Aug; 22 Suppl 2():S27-9. PubMed ID: 24074787 [TBL] [Abstract][Full Text] [Related]
17. Expression of hepaCAM is downregulated in cancers and induces senescence-like growth arrest via a p53/p21-dependent pathway in human breast cancer cells. Moh MC; Zhang T; Lee LH; Shen S Carcinogenesis; 2008 Dec; 29(12):2298-305. PubMed ID: 18845560 [TBL] [Abstract][Full Text] [Related]
18. Activation of a cAMP pathway and induction of melanogenesis correlate with association of p16(INK4) and p27(KIP1) to CDKs, loss of E2F-binding activity, and premature senescence of human melanocytes. Haddad MM; Xu W; Schwahn DJ; Liao F; Medrano EE Exp Cell Res; 1999 Dec; 253(2):561-72. PubMed ID: 10585280 [TBL] [Abstract][Full Text] [Related]
19. p53 Suppresses E2F1-dependent PLK1 expression upon DNA damage by forming p53-E2F1-DNA complex. Zhou Z; Cao JX; Li SY; An GS; Ni JH; Jia HT Exp Cell Res; 2013 Dec; 319(20):3104-15. PubMed ID: 24076372 [TBL] [Abstract][Full Text] [Related]
20. Involvement of E2F1 transcriptional activity in cadmium-induced cell-cycle arrest at G1 in human lung fibroblasts. Choi YJ; Yin HQ; Suh HR; Lee YJ; Park SR; Lee BH Environ Mol Mutagen; 2011 Mar; 52(2):145-52. PubMed ID: 20839231 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]